Pfizer, EU push back COVID vaccine delivery to help booster campaign Pfizer and BioNTech are currently testing other versions of the vaccine targeted at the Omicron variant of the coronavirus
Pharma companies need to limit the presence of nitrosamines in human medicines: EMA Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
Global COVID-19 fundraising meeting raises $6.9 billion, leaders want vaccine for all The money will be used for COVID-19 tests, treatments and vaccines, and also to support the world’s poorest and most…
